MX355103B - Composicion para el tratamiento de desordenes inflamatorios e inmunes. - Google Patents
Composicion para el tratamiento de desordenes inflamatorios e inmunes.Info
- Publication number
- MX355103B MX355103B MX2014011922A MX2014011922A MX355103B MX 355103 B MX355103 B MX 355103B MX 2014011922 A MX2014011922 A MX 2014011922A MX 2014011922 A MX2014011922 A MX 2014011922A MX 355103 B MX355103 B MX 355103B
- Authority
- MX
- Mexico
- Prior art keywords
- inflammatory
- treatment
- composition
- immune disorders
- methylsulphonylmethane
- Prior art date
Links
- 208000026278 immune system disease Diseases 0.000 title abstract 2
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 230000002757 inflammatory effect Effects 0.000 title abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N methylsulphonylmethane Natural products CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 abstract 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012901301A AU2012901301A0 (en) | 2012-04-02 | Treatment of inflammatory and immune disorders | |
| PCT/GB2013/050865 WO2013150292A1 (en) | 2012-04-02 | 2013-04-02 | Composition for the treatment of inflammatory and immune disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014011922A MX2014011922A (es) | 2015-12-03 |
| MX355103B true MX355103B (es) | 2018-04-05 |
Family
ID=48184233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014011922A MX355103B (es) | 2012-04-02 | 2013-04-02 | Composicion para el tratamiento de desordenes inflamatorios e inmunes. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9387218B2 (pt-PT) |
| EP (1) | EP2836208B1 (pt-PT) |
| JP (1) | JP6188784B2 (pt-PT) |
| CN (1) | CN104427982B (pt-PT) |
| AU (1) | AU2013203825B2 (pt-PT) |
| CA (1) | CA2869243C (pt-PT) |
| HK (1) | HK1207293A1 (pt-PT) |
| MX (1) | MX355103B (pt-PT) |
| WO (1) | WO2013150292A1 (pt-PT) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018051154A1 (en) * | 2016-09-15 | 2018-03-22 | Perscellmed Roth & Partner | Compound of zinc salicylate and sulphur combination as a novel treatment for asthma and copd |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4514421A (en) | 1979-08-30 | 1985-04-30 | Herschler R J | Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it |
| US20030069202A1 (en) * | 2000-06-02 | 2003-04-10 | Kern Kenneth Norman | Compositions, kits, and methods for promoting defined health benefits |
| US6902739B2 (en) * | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
| US6841173B2 (en) * | 2002-03-26 | 2005-01-11 | Peter L. Reynolds | Compositions and methods directed towards sore muscles and joints |
| US20060251750A1 (en) * | 2002-09-30 | 2006-11-09 | Tabor Aaron T | Soy formulations and their use in skin care |
| JP2005013124A (ja) * | 2003-06-27 | 2005-01-20 | Toyo Shinyaku:Kk | 美容効果を有する食品組成物 |
| US20050176807A1 (en) * | 2004-02-09 | 2005-08-11 | Friesen Kim G. | Composition and method for use in cartilage affecting conditions |
| US20060029647A1 (en) | 2004-02-09 | 2006-02-09 | Friesen Kim G | Composition and method for use in cartilage affecting conditions |
| US20070020218A1 (en) * | 2005-07-21 | 2007-01-25 | Eileen Richardson | Composition and method for the treatment of psoriasis |
| US7335384B2 (en) * | 2006-03-17 | 2008-02-26 | 4K Nutripharma International | Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith |
| US20090110674A1 (en) * | 2007-10-24 | 2009-04-30 | Loizou Nicos C | Health supplement |
| EP2624821B1 (en) | 2010-10-07 | 2018-06-27 | Eaglepharma Pty Ltd | Combination therapy for the treatment of depression and other non-infectious diseases |
-
2013
- 2013-04-02 CN CN201380028968.9A patent/CN104427982B/zh not_active Expired - Fee Related
- 2013-04-02 US US14/390,184 patent/US9387218B2/en active Active
- 2013-04-02 AU AU2013203825A patent/AU2013203825B2/en active Active
- 2013-04-02 EP EP13718613.6A patent/EP2836208B1/en active Active
- 2013-04-02 JP JP2015503938A patent/JP6188784B2/ja not_active Expired - Fee Related
- 2013-04-02 CA CA2869243A patent/CA2869243C/en not_active Expired - Fee Related
- 2013-04-02 WO PCT/GB2013/050865 patent/WO2013150292A1/en active Application Filing
- 2013-04-02 MX MX2014011922A patent/MX355103B/es active IP Right Grant
-
2015
- 2015-08-14 HK HK15107890.9A patent/HK1207293A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6188784B2 (ja) | 2017-08-30 |
| AU2013203825A1 (en) | 2013-10-17 |
| AU2013203825B2 (en) | 2015-12-17 |
| CN104427982B (zh) | 2017-05-17 |
| EP2836208A1 (en) | 2015-02-18 |
| US9387218B2 (en) | 2016-07-12 |
| CA2869243A1 (en) | 2013-10-10 |
| US20150111850A1 (en) | 2015-04-23 |
| HK1207293A1 (en) | 2016-01-29 |
| CN104427982A (zh) | 2015-03-18 |
| WO2013150292A1 (en) | 2013-10-10 |
| JP2015512439A (ja) | 2015-04-27 |
| MX2014011922A (es) | 2015-12-03 |
| EP2836208B1 (en) | 2019-09-25 |
| CA2869243C (en) | 2021-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA033555B1 (ru) | Фармацевтические композиции для лечения серповидно-клеточного нарушения | |
| HK1206297A1 (en) | Pharmaceutical compositions for combination therapy | |
| MX2015016983A (es) | Moduladores del transporte nuclear y usos de los mismos. | |
| IN2014DN09434A (pt-PT) | ||
| EP3038647A4 (en) | Combination therapy for the treatment of glioblastoma | |
| EP3082817A4 (en) | Compositions for drug administration | |
| TW201144301A (en) | Processes for preparing linezolid | |
| MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
| HRP20190050T1 (hr) | Farmaceutski pripravci za kombinacijsku terapiju | |
| EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
| WO2014160281A3 (en) | Method of enhancing delivery of therapeutic compounds to the eye | |
| AU2018253600A1 (en) | Dosage forms and therapeutic uses of l-4-chlorokynurenine | |
| GEP20196984B (en) | Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder | |
| PT2859896T (pt) | Composições farmacêuticas para o tratamento de distúrbios musculares | |
| EP3020417A4 (en) | Pharmaceutical composition for respiratory administration | |
| WO2014147503A3 (en) | Anti-bag3 antibodies for therapeutic use | |
| MX2015000179A (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
| IN2014DN03010A (pt-PT) | ||
| IN2013MU01111A (pt-PT) | ||
| MX2015007945A (es) | Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas. | |
| IL250201A0 (en) | Administration of erythuran or its salts suitable for pharmaceutical use for the treatment of orthomyxovirus infections | |
| MX2014014814A (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
| MX2014014816A (es) | Composicion farmaceutica para tratar inflamacion y dolor. | |
| MX355103B (es) | Composicion para el tratamiento de desordenes inflamatorios e inmunes. | |
| IN2013CH04314A (pt-PT) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |